Basic treatment of bipolar disorder: Therapeutic advantages and disadvantages of lithium;Therapeutische voor- en nadelen van lithium: Elementaire behandeling van bipolaire stoornis

Pharmaceutisch Weekblad

Volumn 139, Issue 10, 2004, Pages 328-333

  Wilting, Ingeborg ^a,b   Heerdink, E R ^b   Egberts, A C G ^a,b   Nolen, W A ^c  

^a GGZ Midden Brabant   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DESMOPRESSIN; ELECTROLYTE; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT; VASOPRESSIN;

ARTICLE; BIPOLAR DISORDER; DRUG EFFICACY; HUMAN; HYPOTHYROIDISM; NETHERLANDS; POLYDIPSIA; POLYURIA; RISK FACTOR; SECOND MESSENGER;

EID: 1542314777     PISSN: 00316911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet. 2002;359:241-7.
2. Amdisen A. Serum concentration and clinical supervision in monitoring of lithium treatment. Ther Drug Monit. 1980;2(1):73-83.
3. Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949;2:349-52.
4. Schou M, Juel-Nielsen N, Stromgren E, et al. The treatment of manic psychosis by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17:250-60.
5. Burgess S, Geddes J, Hawton K, et al. Lithium for maintenance treatment of mood disorders (Cochrane review). Cochrane library 2003;4.
6. Baldessarini RJ, Tondo L, Hennen J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry. 2003;64(suppl 5):44-52.
7. Tondo L, Hennen J, Baldessarini J. Acta Psychiatar Scand 2001;104:163-72.
8. Dinan TG. Lithium in bipolar mood disorder. Br Med J. 2002;324:989-90.
9. Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry. 2000;48:740-54.
10. Baptista T, Teneud L, Contreras Q, et al. Lithium and body weight gain. Pharmacopsychiatry. 1995;28(2):35-44.
11. Arts BMG, Honig A, Riedel WJ, et al. Cognitive bijwerkingen van lithium: een meta-analyse en aanbevelingen. Tijdschr Psychiatrie. 1998;40:460-8.
12. Boton R, Gaviria m, Battle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10:329-45.
13. Myers DH, Carter RA, Burns BH, et al. A prospective study of the effects of lithium on thyroid function and on the prevalence of antithyroid antibodies. Psychol Med. 1985;1:55-61.
14. Sarantidis D, Waters B. A review and controlled study cutaneous condotions associated with lithium carbonate. Br J Psychiatry. 1983;143:42-50.
15. Goodwin FK, Redfield Jamison K. Manic depressive illness. New York: Oxford University Press; 1990.
16. Cookson J. Lithium: Balancing risks and benefits. Br J Psychiatry. 1997;171:120-4.
17. Gitlin MJ, Cochran SD, Redfield Jamison K. Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry. 1989;50:127-31.
18. Aronson JK, Reynolds DJ. Lithium ABC of monitoring drug therapy. Br Med J. 1992;305:1273-6.
19. Nolen WA, Knoppert-van der Klein EAM, Honig A, et al. Richtlijn voor de diagnostiek en de behandeling van de bipolaire stoornis. Nederlandse Vereniging voor Psychiatrie; december 2001.
20. Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet. 1995;29:172-91.
21. KOMBI/rom, 2003 apr.
22. Kupka RW, Nolen WA, Post RM, et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry. 2002;51(4):305-11.
23. Lindstedt G, Nilsson LA, Wålinder J, et al. On the prevalence, diagnosis and management of lithium-induced hypothyroidism in psychiatric patients. Br J Psychiatry. 1977;130:452-8.
24. Bendz H, Aurell M. Drug-induced diabetes insipidus, incidence, prevention and management. Drug Saf. 1999;21(6):449-56.
25. Movig KLL, Baumgarten R, Leufkens HGM, et al. Risk factors for the development of lithium-induced polyuria. Br J Psychiatry. 2003;182:319-23.
26. Eustatia-Rutten CFA, Tamsma JT, Meinders AE. Lithium-induced nephrogenic diabetes insipidus. Neth J Med. 2001;58:137-42.
27. Lam SS, Kjellstrand C. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs. Ren Fail. 1997;19:183-8.